Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

Blood (2023) 141 (16): 1971–1981.

https://doi.org/10.1182/blood.2022017734

Published: 2023

Includes: Supplemental data

Journal Articles

Time-Sequential Change of the Predictive Power of Peripheral Blood WT1mRNA Levels after Allogeneic Stem Cell Transplantation for Myeloid Neoplasm Relapse and Development of a Dynamic Relapse Prediction Model

Soichiro Nakako, Hiroshi Okamura, Isao Yokota, Yukari Umemoto, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Mitsutaka Nishimoto, Asao Hirose, Mika Nakamae, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino, Hirohisa Nakamae

Blood (2022) 140 (Supplement 1): 3416–3418.

https://doi.org/10.1182/blood-2022-164932

Published: 2022

Journal Articles

A Prospective Comparison Analysis of Blood Biomarkers for the Diagnosis and Prediction of Sinusoidal Obstruction Syndrome

Naonori Harada, Hiroshi Okamura, Hideo Koh, Nao Tanizawa, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Asao Hirose, Mika Nakamae, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hirohisa Nakamae, Masayuki Hino

Blood (2021) 138 (Supplement 1): 2865.

https://doi.org/10.1182/blood-2021-146497

Published: 2021

Journal Articles

Pretransplant Plasma Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide Are More Useful Prognostic Markers of Overall Survival after Allogeneic Hematopoietic Cell Transplantation Than Echocardiography

Naonori Harada, Hiroshi Okamura, MD PhD, Takahiko Nakane, MD PhD, Shiro Koh, MDPhD, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Asao Hirose, MD PhD, Mika Nakamae, MD PhD, Yasuhiro Nakashima, MD PhD, Hideo Koh, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-134223

Published: 2020

Journal Articles

Impact of Donor KIR and HLA Genotypes on Clinical Outcomes According to Pre-Transplant Remission Status after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide

Kentaro Ido, MD, Hideo Koh, MD PhD, Hiroshi Okamura, MD PhD, Shiro Koh, MD PhD, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Asao Hirose, MD PhD, Mika Nakamae, MD PhD, Yasuhiro Nakashima, MD PhD, Takahiko Nakane, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2019) 134 (Supplement_1): 2030.

https://doi.org/10.1182/blood-2019-125173

Published: 2019

Journal Articles

Pretransplant Risk Factors for Calcineurin Inhibitor-Induced Encephalopathy and Limbic Encephalitis Following Allogeneic Hematopoietic Cell Transplantation

Nao Tanizawa, MD, Hideo Koh, MD PhD, Hiroshi Okamura, MD PhD, Koh Shiro, MD PhD, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Asao Hirose, MD PhD, Mika Nakamae, MD PhD, Yasuhiro Nakashima, MD PhD, Takahiko Nakane, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2019) 134 (Supplement_1): 4492.

https://doi.org/10.1182/blood-2019-124264

Published: 2019

Journal Articles

Pre-Transplant Serum Beta-2 Microglobulin Level Is a Potential Novel Prognostic Marker for Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation

Naonori Harada, Takahiko Nakane, MD PhD, Mika Nakamae, MD PhD, Hiroshi Okamura, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Yasunobu Takeoka, MD PhD, Asao Hirose, MD PhD, Yasuhiro Nakashima, MD PhD, Hideo Koh, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2018) 132 (Supplement 1): 4664.

https://doi.org/10.1182/blood-2018-99-111679

Published: 2018

Journal Articles

The Proportional Association between WT1 mRNA Level in Peripheral Blood before Allogeneic Hematopoietic Cell Transplantation and Risk of Mortality in Acute Myeloid Leukemia Not in Remission

Kentaro Ido, MD, Mika Nakamae, MDPhD, Hideo Koh, MDPhD, Hiroshi Okamura, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MDPhD, Yoshinori Hashimoto, MD, Yasunobu Takeoka, MDPhD, Asao Hirose, MDPhD, Yasuhiro Nakashima, MDPhD, Takahiko Nakane, MD PhD, Masayuki Hino, MDPhD, Hirohisa Nakamae, MDPhD

Blood (2018) 132 (Supplement 1): 4665.

https://doi.org/10.1182/blood-2018-99-111834

Published: 2018

Journal Articles

Noninvasive Diagnostic Approach By per Rectal Portal Scintigraphy for Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Cell Transplantation

Blood (2018) 132 (Supplement 1): 2087.

https://doi.org/10.1182/blood-2018-99-110517

Published: 2018

Journal Articles

Pre-Transplant Transferrin Saturation Levels As a Predictive Marker for Invasive Fungal Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Satoru Nanno, MDPhD, Hideo Koh, MDPhD, Mitsutaka Nishimoto, MDPhD, Takahiko Nakane, MDPhD, Yasuhiro Nakashima, MDPhD, Yasunobu Takeoka, MDPhD, Mika Nakamae, MDPhD, Asao Hirose, MDPhD, Masayuki Hino, MDPhD, Hirohisa Nakamae, MDPhD

Blood (2017) 130 (Supplement 1): 1965.

https://doi.org/10.1182/blood.V130.Suppl_1.1965.1965

Published: 2017

Journal Articles

Post-Transplant Cyclophosphamide Contributes to Impaired Graft-Versus-Leukemia Effects and Regulates Graft-Versus-Host Disease in the Murine Stem Cell Transplant Model

Yosuke Makuuchi, MD, Yasuhiro Nakashima, MDPhD, Hideo Koh, MDPhD, Takahiko Nakane, MDPhD, Hirohisa Nakamae, MDPhD, Masayuki Hino, MDPhD

Blood (2017) 130 (Supplement 1): 4448.

https://doi.org/10.1182/blood.V130.Suppl_1.4448.4448

Published: 2017

Journal Articles

Short-Term Fasting Induces Cell Cycle Arrest of Immature Hematopoietic Cells and Increases the Number of Naive T Cells in the Bone Marrow of Mice

Teruhito Takakuwa, MD, Yasuhiro Nakashima, MD, PhD, Hideo Koh, MD,PhD, Takahiko Nakane, MD, PhD, Hirohisa Nakamae, MD PhD, Masayuki Hino, MD, PhD

Blood (2016) 128 (22): 5047.

https://doi.org/10.1182/blood.V128.22.5047.5047

Published: 2016

Journal Articles

Prophylactic Use of a Combination of an Anticoagulant and Ursodeoxycholic Acid for Sinusoidal Obstruction Syndrome after Allogeneic Myeloablative Hematopoietic Stem Cell Transplantation

Hiroshi Okamura, MD, Mitsutaka Nishimoto, MD,PhD, Takahiko Nakane, MD, PhD, Hideo Koh, MD,PhD, Yasuhiro Nakashima, MD, PhD, Yasunobu Takeoka, MD, PhD, Mika Nakamae, MD,PhD, Asao Hirose, MD, PhD, Masayuki Hino, MD, PhD, Hirohisa Nakamae, MD PhD

Blood (2016) 128 (22): 5755.

https://doi.org/10.1182/blood.V128.22.5755.5755

Published: 2016

Journal Articles

Pre-Transplant Autonomic Nervous System Malfunction Is a Powerful Predictor for Survival after Allogeneic Hematopoietic Cell Transplantation

Takahiko Nakane, MD, PhD, Mika Nakamae, MD,PhD, Hideo Koh, MD,PhD, Mitsutaka Nishimoto, MD,PhD, Yoshiki Hayashi, MD,PhD, Asao Hirose, MD,PhD, Yasuhiro Nakashima, MD,PhD, Masayuki Hino, Hirohisa Nakamae, MD,PhD

Blood (2015) 126 (23): 3205.

https://doi.org/10.1182/blood.V126.23.3205.3205

Published: 2015

Journal Articles

Effectiveness of Antibacterial Prophylaxis with Non-Absorbable Polymyxin B Compared to Levofloxacin after Allogeneic Hematopoietic Stem Cell Transplantation

Shiro Koh, MD, Hirohisa Nakamae, Koichi Yamada, MD, PhD, Mitsutaka Nishimoto, MD, PhD, Yoshiki Hayashi, MD, PhD, Hideo Koh, MD, PhD, Yasuhiro Nakashima, MD, PhD, Takahiko Nakane, MD, PhD, Asao Hirose, MD, PhD, Mika Nakamae, MD, PhD, Hiroshi Kakeya, MD, PhD, Masayuki Hino, MD, PhD

Blood (2014) 124 (21): 1145.

https://doi.org/10.1182/blood.V124.21.1145.1145

Published: 2014

Journal Articles

The V50/V25 Ratio, a Marker of Small Airway Disease, Is Highly Predictive of Survival after Allogeneic Hematopoietic Cell Transplantation

Mika Nakamae, MD, PhD, Hirohisa Nakamae, Mariko Yamashita, Mitsutaka Nishimoto, MD, PhD, Yoshiki Hayashi, MD, PhD, Hideo Koh, MD, PhD, Takahiko Nakane, MD, PhD, Yasuhiro Nakashima, MD, PhD, Asao Hirose, MD, PhD, Masayuki Hino, MD, PhD

Blood (2014) 124 (21): 1208.

https://doi.org/10.1182/blood.V124.21.1208.1208

Published: 2014

Journal Articles

HLA Haplo-Identical Peripheral Blood Stem Cell Transplantation Using High-Dose Cyclophosphamide Post-Transplantation For Poor Prognosis Or Refractory Acute Leukemia and Myelodysplastic Syndrome: A Prospective Pilot Study At a Single Center

Hirohisa Nakamae, MD, PhD, Hideo Koh, M.D., Ph.D., Mitsutaka Nishimoto, M.D., Ph.D., Yasuhiro Nakashima, M.D., Ph.D., Satoru Nanno, M.D., Takuro Yoshimura, M.D., Ph.D., Shiro Koh, M.D., Hiroshi Okamura, M.D., Jyoji Nagasaki, M.D., Takahiko Nakane, M.D., Ph.D., Mika Nakamae, M.D., Ph.D., Asao Hirose, M.D., Ph.D., Masayuki Hino, MD, PhD

Blood (2013) 122 (21): 3404.

https://doi.org/10.1182/blood.V122.21.3404.3404

Published: 2013

Journal Articles

Diagnostic Value Of Serum Level Of Soluble CD14-Subtype In Febrile Neutropenia In Patients With Hematologic Disorders

Hideo Koh, M.D., Ph.D., Hirohisa Nakamae, MD, PhD, Mizuki Aimoto, M.D., Takako Katayama, Asao Hirose, M.D., Ph.D., Mika Nakamae, M.D., Ph.D., Masayuki Hino, MD, PhD

Blood (2013) 122 (21): 4718.

https://doi.org/10.1182/blood.V122.21.4718.4718

Published: 2013

Journal Articles

Prognostic Value for Survival of Serum Ferritin Levels Over Time After Allogeneic Hematopoietic Cell Transplantation

Mika Nakamae, MD, PhD, Hirohisa Nakamae, MD, PhD, Hideo Koh, MD, PhD, Takahiko Nakane, MD, PhD, Mitsutaka Nishimoto, MD, Asao Hirose, MD, PhD., Masayuki Hino

Blood (2012) 120 (21): 4466.

https://doi.org/10.1182/blood.V120.21.4466.4466

Published: 2012

Journal Articles

Immunoprofile of Patients with Chronic Myeloid Leukemia Treated with Imatinib, Nilotinib or Dasatinib,

Yoshiki Hayashi, M.D., Hirohisa Nakamae, MD, PhD, Takako Katayama, Takahiko Nakane, M.D., Ph.D., Hideo Koh, M.D., Ph.D, Mitsutaka Nishimoto, M.D., Mika Nakamae, M.D., Ph.D, Masahiro Yoshida, M.D., Masato Bingo, M.D., Hiroshi Okamura, M.D., Mizuki Aimoto, M.D., Masahiro Manabe, M.D., Takuro Yoshimura, M.D., Akiko Inaba, M.D., Satoshi Nanno, M.D., Kiyoyuki Hagihara, M.D., Ph.D, Yoshitaka Nakao, M.D., Ph.D, Yoshiki Terada, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2011) 118 (21): 3764.

https://doi.org/10.1182/blood.V118.21.3764.3764

Published: 2011

NARROW

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

Time-Sequential Change of the Predictive Power of Peripheral Blood WT1mRNA Levels after Allogeneic Stem Cell Transplantation for Myeloid Neoplasm Relapse and Development of a Dynamic Relapse Prediction Model

A Prospective Comparison Analysis of Blood Biomarkers for the Diagnosis and Prediction of Sinusoidal Obstruction Syndrome

Pretransplant Plasma Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide Are More Useful Prognostic Markers of Overall Survival after Allogeneic Hematopoietic Cell Transplantation Than Echocardiography

Impact of Donor KIR and HLA Genotypes on Clinical Outcomes According to Pre-Transplant Remission Status after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide

Pretransplant Risk Factors for Calcineurin Inhibitor-Induced Encephalopathy and Limbic Encephalitis Following Allogeneic Hematopoietic Cell Transplantation

Pre-Transplant Serum Beta-2 Microglobulin Level Is a Potential Novel Prognostic Marker for Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation

The Proportional Association between WT1 mRNA Level in Peripheral Blood before Allogeneic Hematopoietic Cell Transplantation and Risk of Mortality in Acute Myeloid Leukemia Not in Remission

Noninvasive Diagnostic Approach By per Rectal Portal Scintigraphy for Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Cell Transplantation

Pre-Transplant Transferrin Saturation Levels As a Predictive Marker for Invasive Fungal Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Post-Transplant Cyclophosphamide Contributes to Impaired Graft-Versus-Leukemia Effects and Regulates Graft-Versus-Host Disease in the Murine Stem Cell Transplant Model

Short-Term Fasting Induces Cell Cycle Arrest of Immature Hematopoietic Cells and Increases the Number of Naive T Cells in the Bone Marrow of Mice

Prophylactic Use of a Combination of an Anticoagulant and Ursodeoxycholic Acid for Sinusoidal Obstruction Syndrome after Allogeneic Myeloablative Hematopoietic Stem Cell Transplantation

Pre-Transplant Autonomic Nervous System Malfunction Is a Powerful Predictor for Survival after Allogeneic Hematopoietic Cell Transplantation

Effectiveness of Antibacterial Prophylaxis with Non-Absorbable Polymyxin B Compared to Levofloxacin after Allogeneic Hematopoietic Stem Cell Transplantation

The V50/V25 Ratio, a Marker of Small Airway Disease, Is Highly Predictive of Survival after Allogeneic Hematopoietic Cell Transplantation

HLA Haplo-Identical Peripheral Blood Stem Cell Transplantation Using High-Dose Cyclophosphamide Post-Transplantation For Poor Prognosis Or Refractory Acute Leukemia and Myelodysplastic Syndrome: A Prospective Pilot Study At a Single Center

Diagnostic Value Of Serum Level Of Soluble CD14-Subtype In Febrile Neutropenia In Patients With Hematologic Disorders

Prognostic Value for Survival of Serum Ferritin Levels Over Time After Allogeneic Hematopoietic Cell Transplantation

Immunoprofile of Patients with Chronic Myeloid Leukemia Treated with Imatinib, Nilotinib or Dasatinib,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only